Related Experiment Videos
Experimental neuroprotection in ischemic stroke: a concise review
1Department of Neurosurgery, University Health Center, Wayne State University, Detroit Michigan.
Neurosurgical Focus
|April 4, 2017
Summary
Neuroprotective therapies for acute ischemic stroke (AIS) show promise in preclinical models but have not translated to clinical use. This review examines current clinical studies and preclinical neuroprotective strategies for AIS.
Area of Science:
- Neurology
- Neuroscience
- Pharmacology
Background:
- Acute ischemic stroke (AIS) is a major global cause of death and disability.
- Current standard treatments for AIS include intravenous thrombolysis and mechanical thrombectomy.
- Despite advances in diagnostics and endovascular devices, effective neuroprotective therapies remain elusive.
Purpose of the Study:
- To review clinical studies on neuroprotection in AIS.
- To summarize preclinical neuroprotective therapies, their mechanisms, and potential clinical applications.
Main Methods:
- Literature review of clinical trials investigating neuroprotective agents for AIS.
- Analysis of preclinical research on neuroprotective strategies and their proposed mechanisms of action.
Main Results:
- Many neuroprotective therapies have demonstrated efficacy in experimental stroke models.
- A significant gap exists between preclinical findings and successful clinical translation for neuroprotection in AIS.
Conclusions:
- Neuroprotection remains a critical unmet need in acute ischemic stroke management.
- Further research is needed to bridge the gap between preclinical promise and clinical reality for neuroprotective therapies in AIS.